Valneva SE
Specialty vaccine company developing and commercializing vaccines for infectious diseases.
VLA | PA
Overview
Corporate Details
- ISIN(s):
- AT0000A10B99 (+3 more)
- LEI:
- 969500DIVIP5VKNW4948
- Country:
- France
- Address:
- 6 RUE ALAIN BOMBARD, 44800 SAINT-HERBLAIN
- Website:
- https://valneva.com/
- Sector:
- Manufacturing
Description
Valneva SE is a specialty vaccine company that develops, manufactures, and commercializes prophylactic vaccines for infectious diseases with unmet medical needs. The company has leveraged its expertise to commercialize three vaccines, including a single-shot vaccine for chikungunya. Its research and development pipeline features a broad range of vaccine candidates, including those targeting Lyme disease, Shigella, and Zika.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2021-12-16 07:00 |
Valneva Announces Positive Homologous Booster Data for Inactivated, Adjuvanted …
|
English | 336.8 KB | ||
| 2021-12-08 07:00 |
Valneva Signs Advance Purchase Agreement with Bahrain for Inactivated COVID-19 …
|
English | 309.7 KB | ||
| 2021-12-08 07:00 |
Valneva annonce la signature d’un accord d'achat anticipé avec Bahreïn pour son…
|
French | 468.9 KB | ||
| 2021-12-06 08:30 |
Déclaration d’actions et de droits de vote de la société Valneva SE - Novembre …
|
French | 352.0 KB | ||
| 2021-12-06 08:30 |
Valneva SE: declaration of shares and voting rights - November 2021
|
English | 102.0 KB | ||
| 2021-12-03 17:45 |
Valneva commente les données de l'essai COV-Boost
|
French | 317.3 KB | ||
| 2021-12-03 17:45 |
Valneva Comments on COV-Boost Clinical Trial Data
|
English | 312.1 KB | ||
| 2021-12-02 17:45 |
Valneva débute la soumission progressive du dossier d’enregistrement auprès de …
|
French | 398.7 KB | ||
| 2021-12-02 17:45 |
Valneva Confirms Initiation of Rolling Review with EMA and Provides Updates on …
|
English | 310.2 KB | ||
| 2021-11-29 17:45 |
Valneva et IDT Biologika annoncent leur collaboration pour la production du vac…
|
French | 402.0 KB | ||
| 2021-11-29 17:45 |
Valneva and IDT Biologika Announce Collaboration for Production of Inactivated …
|
English | 312.9 KB | ||
| 2021-11-23 18:40 |
Valneva signe un accord d’achat avec la Commission européenne pour son vaccin i…
|
French | 459.2 KB | ||
| 2021-11-23 18:40 |
Valneva Signs Purchase Agreement with European Commission for its Inactivated C…
|
English | 300.7 KB | ||
| 2021-11-18 07:00 |
Valneva publie son chiffre d’affaires et sa trésorerie pour les neuf premiers m…
|
French | 532.8 KB | ||
| 2021-11-18 07:00 |
Valneva Reports Nine-Month 2021 Revenue and Cash
|
English | 712.1 KB |
Automate Your Workflow. Get a real-time feed of all Valneva SE filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Valneva SE
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Valneva SE via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-03-18 | N/A | Other | Buy | 44,222 | N/A |
| 2024-01-03 | N/A | Other | Other | 34,802 | N/A |
| 2023-06-20 | N/A | Other | Sell | 192,547 | 1,406,228.50 EUR |
| 2023-06-19 | N/A | Other | Sell | 30,661 | 209,629.26 EUR |
| 2023-06-16 | N/A | Other | Sell | 85,589 | 582,493.06 EUR |
| 2023-06-15 | N/A | Other | Sell | 28,179 | 189,503.78 EUR |
| 2023-06-14 | N/A | Other | Sell | 228,951 | 1,519,914.11 EUR |
| 2023-06-13 | N/A | Other | Sell | 29,401 | 187,922.37 EUR |
| 2023-06-12 | N/A | Other | Sell | 117,854 | 733,782.57 EUR |
| 2023-05-10 | N/A | Other | Buy | 87,523 | N/A |
Peer Companies
